2017 American Transplant Congress

Sunday, April 30, 2017

8:30am-8:45am

Transplanting Hepatitis C Kidneys into Negative KidnEy Recipients [THINKER] Trial.

D. Goldberg, E. Blumberg, R. Reddy, S. Nazarian, V. Van Deerlin, J. Trofe-Clarke, M. Levine, D. Sawinski, R. Bloom, P. Abt, P. Reese.

Joint Plenary Session I  •  Arie Crown Theater

8:45am-9:00am

EXPANDER-1: Exploring Renal Transplants Using Hepatitis-C Infected Donors for HCV-Negative Recipients.

C. Durand, D. Brown, R. Wesson, N. Bhair, F. Naqvi, D. Ostrander, M. Bowring, A. Massie, S. Rasmussen, J. Sugarman, D. Segev, M. Sulkowski, N. Desai.

Joint Plenary Session I  •  Arie Crown Theater

9:00am-9:15am

Emerging Application of Active Immune Targeted Delivery in Transplantation.

M. Uehara,¹ J. Azzi,¹ B. Bahmani,^1,2 J. Cheng,³ Q. Yin,³ L. Tang,³ K. Cai,³ Q. Sun,³ M. Kwon,³ Q. Xu,² G. Brandacher,⁴ R. Abdi.¹

Joint Plenary Session I  •  Arie Crown Theater

9:15am-9:30am

Uptake of Extracellular Mitochondria Activates Human Endothelial Cells That Stimulate Alloreactive Effector T Cell Responses.

T. Brennan,¹ F. Feng,¹ L. Lin,¹ M. Song,¹ Q.-J. Li,² A. Kirk,^1,2 H. Xu.¹

Joint Plenary Session I  •  Arie Crown Theater

2:30pm-2:42pm

De Novo Donor-Specific Antibodies After Allograft Nephrectomy.

G. Lucisano,¹ P. Brookes,² E. Santos-Nunez,² N. Firmin,² N. Gunby,² S. Hassan,¹ A. Gueret-Wardle,¹ M. Willicombe,¹ D. Taube.¹

Concurrent Session: Kidney HLA Antibodies  •  E354b

2:30pm-2:42pm

Characterization of a B Lymphocyte Signature Predictive of Chronic Lung Allograft Dysfunction.

C. Brosseau,^1,2 M. Durand,^1,2 E. Durand,^1,2 J. Loy,² A. Foureau,² P. Lacoste,² P.-J. Royer,² A. Magnan,² S. Brouard.¹

Concurrent Session: B Cells in Alloimmunity  •  E350

2:30pm-2:42pm

Clinical Significance of Alloantibodies in Hand Transplantation: Impact on Rejection and Functional Outcome.

E. Berglund,¹ M. Andersen Ljungdahl,¹ D. Bogdanovic,¹ D. Berglund,³ J. Wadström,¹ A. Weissenbacher,² P. Petruzzo,⁴ S. Schneeberger.²

Concurrent Session: VCA  •  E270

2:30pm-2:42pm

Contribution of New Generation Sequencing to CMV Resistance Analysis in Renal Transplant Recipients (on Behalf of the CMV Resist Group).

C. Danthu,¹ M. Gomes-Mayeras,¹ D. Andouard,² E. Munteanu,¹ R. Moulinas,^1,4 G. Ligat,² S. Hantz,^1,2 J. Rerolle,³ F. Garnier,¹ M. Essig,³ S. Alain.^1,2,4

Concurrent Session: Cutting Edge - Cytomegalovirus  •  E353C

2:30pm-2:42pm

Disease Progression on Neoadjuvant Chemotherapy Is a Strong Predictor of Recurrence for Pediatric Hepatoblastoma.

M. Kueht,¹ S. Commander,¹ T.-A. Ha,¹ A. Rana,^1,2 Y. Shi,¹ S. Vasudevan,^1,2 J. Goss.^1,2

Concurrent Session: Pediatric Liver  •  E271a

2:30pm-2:42pm

High Regulatory T Cells Rate Early After Lung Transplantation Is Associated with Bronchiolitis Obliterans Syndrome Development.

M. Durand,^1,2 P. Lacoste,^2,3 C. Brosseau,^1,3 E. Durand,³ J. Loy,³ K. Henrio,^2,3 R. Danger,¹ P. Royer,³ A. Fourreau,³ A. Magnan,^3,4 S. Brouard.¹

Concurrent Session: Predicting Tolerance and Rejection  •  E351